Fusion Pharma: AstraZeneca completes acquisition of Fusion Pharma
AstraZeneca announced the successful completion of the acquisition of Fusion Pharmaceuticals Inc., a clinical─stage biopharmaceutical company developing next─generation radioconjugates (RCs). The acquisition marks
Read full article »
Fusion Pharma is a Canada-based biopharmaceutical company that researches and develops radiation therapies for the treatment of cancer.
Read more